Fall Skin Care Sale

Life Extension Update

November 04, 2004 Printer Friendly
In this issue

Life Extension Update Exclusive:

Vitamin E may be helpful in Alzheimer’s disease prevention

Protocol:

Alzheimer’s disease

Featured Products:

Gamma E Tocopherol/Tocotrienols

Huperzine A

Life Extension Magazine November 2004 issue:

In the News: Memantine found effective against Alzheimer’s disease

Life Extension Update Exclusive

Vitamin E may be helpful in Alzheimer’s disease prevention
The results of research reported in the October 2004 issue of the Journal of Alzheimer’s Disease identifies a culprit in Alzheimer’s disease and shows vitamin E may help slow the destruction of brain cells that occurs as a result.

In a study funded by the National Institutes of Health, University of Kentucky chemistry professor Allan Butterfield and colleagues compared rat and human forms of amyloid beta peptide, a compound that forms the plaques in the brains of Alzheimer’s patients which are believed to be responsible for the damage incurred by this disease. They found that amyloid beta peptide from both rats and humans caused DNA fragmentation in neurons, a loss of neuron connections, and lowered cell viability.

It had previously been proposed that copper binding sites in human amyloid beta contributed to the disease. In the current study, Dr Butterfield’s findings show that rat amyloid beta, which lacks copper binding sites, still causes damage, and that it is the methionine residue in beta amyloid that damages brain cells.

Methionine is an amino acid that occurs in relatively high amounts in animal-derived proteins and contributes to the formation of homocysteine, another amino acid that when elevated has been determined to double the risk of developing Alzheimer’s disease. Earlier research had revealed that methionine was involved in the neurotoxicity and oxidative stress caused by amyloid beta in humans.

Protein oxidation and lipid peroxidation were similar in both animal and human amyloid beta and were both inhibited by vitamin E, an antioxidant vitamin. Studies have found an association between vitamin E intake and reduced cognitive decline and Alzheimer’s disease, adding evidence to the suggestion that it may help retard the disease in humans.

The findings indicate that that reactive oxygen species play a role in the toxicity of amyloid beta peptide, and that the oxidative stress it causes may be due to methionine rather than copper.

Protocol

Alzheimer’s disease
The most characteristic features of Alzheimer's disease are senile plaques of beta-amyloid peptide, neurofibrillary tangles involving tau protein, loss of synapses, and (ultimately) the death of neurons. Although neurofibrillary tangles are more closely associated with neuronal death than beta-amyloid, the evidence is becoming convincing that beta-amyloid is the factor most responsible for starting the degenerative processes of Alzheimer's disease.

Researchers have shown that cultured cells are prevented from beta-amyloid toxicity with the addition of vitamin E (Grundman 2000). Researchers at the University of Kentucky published a ground-breaking article showing that vitamin E prevented the increase of polyamine metabolism in response to free-radical mediated oxidative stress caused by the addition of beta-amyloid to the rat neurons (Yatin et al. 1999).

Research conducted in Germany showed that both natural and synthetic vitamin E were more effective than estrogen (17-beta estradiol) in protecting neurons against oxidative death caused by beta-amyloid, hydrogen peroxide, and the excitatory amino acid glutamate (Behl 2000).

Research conducted at the University of California, San Diego, School of Medicine studied the protective effects of vitamin E in apolipoprotein E-deficient mice. Those treated with vitamin E displayed a significantly improved behavioral performance in the Morris water maze. Also, the untreated mice displayed increased levels of lipid peroxidation and glutathione, whereas the vitamin E-treated mice showed near normal levels of both lipid peroxidation and glutathione (Veinbergs et al. 2000).

A study of 44 patients with Alzheimer's disease and 37 matched controls showed that vitamin E levels in the cerebrospinal fluid (CSF) and serum were significantly lower in Alzheimer's patients (Jimenez-Jimenez et al. 1997).

In the Alzheimer's Disease Cooperative Study, 2000 mg of vitamin E were given to Alzheimer's disease patients. This slowed the functional deterioration leading to nursing home placement (Grundman 2000).

An article by Sano et al. (1997) described a double-blind, placebo-controlled, randomized, multicenter trial of patients with Alzheimer's disease of moderate severity. A total of 341 patients received the selective monoamine oxidase inhibitor selegiline (10 mg a day), alpha-tocopherol (vitamin E, 2000 IU a day), both selegiline and alpha-tocopherol, or placebo for two years. The baseline score on the Mini-Mental State Examination was higher in the placebo group than in the other three groups. Both vitamin E and selegeline delayed the progression of the disease with vitamin E acting slightly better than selegeline (median time 670 vs. 655 days, respectively).

http://www.lef.org/protocols/prtcl-006.shtml

Featured Products

Gamma E Tocopherol/Tocotrienols softgel capsules

One or more members of the vitamin E family may:

  • Maintain cell membrane integrity and reduce cellular aging.
  • Inhibit the potentially damaging peroxynitrite radical.
  • Maintain healthy platelet aggregation.
  • Synergize with vitamin A to protect the lungs against pollutants.
  • Protect nervous system and retina.
  • Delay cognitive decline.
  • Enhance immune function.

http://www.lef.org/newshop/items/item00559.html

Huperzine A

This standardized extract from the Chinese club moss is an all-natural herbal supplement that may help prevent the breakdown of acetylcholine.

This product is standardized for maximum efficacy, and its patented delivery system that includes fat-soluble vitamin E increases absorption.

http://www.lef.org/newshop/items/item00627.html

Life Extension Magazine November 2004 issue

In the News: Memantine found effective against Alzheimer’s disease

Memantine is an N-methyl- D-aspartate (NMDA) receptor antagonist that is neuroprotective by blocking glutamate, which can cause overstimulation of the nerves and become toxic to the nervous system. Memantine may benefit individuals with Alzheimer’s disease by improving cognition and overall functioning.

http://www.lef.org/magazine/mag2004/nov2004_itn_01.htm

If you have questions or comments concerning this issue or past issues of Life Extension Update, send them to ddye@lifeextension.com or call 954 766 8433 extension 7716.

For longer life,

Dayna Dye
Editor, Life Extension Update
ddye@lifeextension.com
LifeExtension.com
1100 West Commercial Boulevard
Fort Lauderdale FL 33309
954 766 8433 extension 7716

Sign up for Life Extension Update at http://mycart.lef.org/subscribe.asp

Help spread the good news about living longer and healthier. Forward this email to a friend!

View previous issues of Life Extension Update in the Newsletter Archive.